Tom Kineshanko - Filament Health CoFounder
| FH Stock | 0.03 0.01 20.00% |
Founder
Tom Kineshanko is CoFounder of Filament Health Corp
| Age | 39 |
| Address | 4475 Wayburne Drive, Burnaby, BC, Canada, V5G 4X4 |
| Web | https://filament.health |
Filament Health Management Efficiency
The company has return on total asset (ROA) of (0.4429) % which means that it has lost $0.4429 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6647) %, meaning that it generated substantial loss on money invested by shareholders. Filament Health's management efficiency ratios could be used to measure how well Filament Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Filament Health's Total Assets are very stable compared to the past year. As of the 23rd of March 2025, Net Tangible Assets is likely to grow to about 3.3 M, while Intangible Assets are likely to drop about 368 K. Filament Health Corp (FH) is traded on NEO Exchange in Canada and employs 13 people. Filament Health is listed under Pharmaceuticals category by Fama And French industry classification.Management Performance
| Return On Equity | -1.66 | ||||
| Return On Asset | -0.44 |
Filament Health Corp Leadership Team
Elected by the shareholders, the Filament Health's board of directors comprises two types of representatives: Filament Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Filament. The board's role is to monitor Filament Health's management team and ensure that shareholders' interests are well served. Filament Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Filament Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Warren CPA, Chief Officer | ||
| Tom Kineshanko, CoFounder | ||
| Steven CPA, Interim Officer | ||
| MB BA, Head Partnerships | ||
| Jon Conlin, Corp Director | ||
| Jonathan Conlin, Corporate Director | ||
| Jeff Fellows, Head Regulatory | ||
| Andry Tjahyana, VP Development | ||
| Benjamin Lightburn, CEO CoFounder | ||
| Warren Duncan, Chief Officer | ||
| Lisa Ranken, Chief Officer | ||
| Anna Cordon, Director Communications | ||
| Ryan Moss, Chief Officer |
Filament Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Filament Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.66 | ||||
| Return On Asset | -0.44 | ||||
| Profit Margin | (1.92) % | ||||
| Operating Margin | (46.15) % | ||||
| Current Valuation | 7.28 M | ||||
| Shares Outstanding | 261.79 M | ||||
| Shares Owned By Insiders | 61.20 % | ||||
| Price To Book | 3.15 X | ||||
| Price To Sales | 3.64 X | ||||
| Revenue | 2.13 M |
Pair Trading with Filament Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Filament Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Filament Health will appreciate offsetting losses from the drop in the long position's value.Moving against Filament Stock
The ability to find closely correlated positions to Filament Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Filament Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Filament Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Filament Health Corp to buy it.
The correlation of Filament Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Filament Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Filament Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Filament Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Filament Stock
Filament Health financial ratios help investors to determine whether Filament Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Filament with respect to the benefits of owning Filament Health security.